The detailed presentation by William E Boden starts with key management considerations and with an excursus on pharmacologic therapy from 2000 to 2020 and the contemporary era of intensive medical therapy, with data coming from COURAGE, BARI 2D, FAME-2, ORBITA, ISCHEMIA trials.